Breaking News
August 20, 2018 - New assay may help improve both sarcoma diagnosis and treatment
August 20, 2018 - New class of insect repellents to fight against mosquito-borne diseases
August 20, 2018 - ACA Coverage Gains Include Workers Without Insurance
August 20, 2018 - 3-D printed biomaterials for bone tissue engineering
August 20, 2018 - Prenatal exposure to acute stress can affect cognitive function in children of low-income households
August 20, 2018 - Researchers find long-term structural, functional brain abnormalities in individuals with AUDs
August 20, 2018 - Shortage of insurance fraud cops sparks campaign debate
August 20, 2018 - Researchers find STAT3 as therapeutic target for chronic active EBV infection
August 20, 2018 - Health Tip: Keep Diabetic Feet Healthier
August 20, 2018 - FDA approves brain stimulation device for OCD
August 20, 2018 - NYU Langone’s Perlmutter Cancer Center expands Blood and Marrow Transplant Program
August 20, 2018 - New drug shows potential to prevent painful side effect of therapy
August 20, 2018 - RDMD raises $3 million in seed funding to accelerate rare disease research, drug development
August 20, 2018 - Illicit drug use is higher during celebratory events, may be worse than previously thought
August 20, 2018 - Exploring the relationship between fever and cancer incidence
August 20, 2018 - Study reveals how socioeconomic status affects racial, ethnic disparities in childhood cancer survival
August 20, 2018 - Brain tumors trap immune cells needed to fight cancer in the bone marrow, finds research
August 20, 2018 - Three factors that contribute to physician burnout
August 20, 2018 - Babies dependent on opioids need touch, not tech
August 20, 2018 - Understanding How Antibodies Shape the Gut Microbiome
August 20, 2018 - Cara Therapeutics Doses First Patient in Second Pivotal Phase 3 Efficacy Trial of Korsuva (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus
August 20, 2018 - Kidney transplant chains more effective in saving lives
August 20, 2018 - Study unravels cellular and molecular mechanisms behind dermal condensate formation
August 20, 2018 - New integrated gene logic-chips could have great value in medical care
August 20, 2018 - FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline
August 20, 2018 - Total, open repairs decline for abdominal aortic aneurysms
August 20, 2018 - Novel system can pinpoint ingestible implants inside the body using wireless signals
August 20, 2018 - Infection rates of high risk oral HPV in England found to be lower than expected
August 20, 2018 - Making robots as valuable and trustworthy assistants for medical therapies
August 20, 2018 - Patients with low-risk blood clots can be better treated at home than at hospital
August 20, 2018 - Passive smoking exposure among kids greatly increases COPD risk late in life
August 20, 2018 - Primary Care Provider Burnout Rate Low in Small Practices
August 20, 2018 - Discovery presents treatment hope for Alzheimer’s and other neurodegenerative diseases
August 20, 2018 - Stroke patients appear to receive better care at teaching hospitals with less chance of readmission
August 20, 2018 - Distinct origin of ADHD identified In children with history of traumatic brain injury
August 20, 2018 - AHA: Wildfire Smoke Threatens Health of Those Near and Far
August 20, 2018 - Here’s a mental health workout that’s as simple as ABC
August 20, 2018 - Newly discovered cytoskeleton utilized by cancer cells for survival
August 19, 2018 - Bifidobacteria supplement colonizes gut of breastfed infants
August 19, 2018 - Why patients with Alzheimer’s markers never develop the condition
August 19, 2018 - ACA’s Medicaid expansion associated with increase in prescriptions for opioid use disorder treatment
August 19, 2018 - Important factor may be missing in models used to predict spread of epidemics from climate change
August 19, 2018 - Indian-Americans have fewer sudden infant deaths, study finds
August 19, 2018 - Experts advise against universal genomic screening of newborns
August 19, 2018 - New trial to investigate whether weight loss before conception can make mom and baby healthier
August 19, 2018 - Sun Pharma Announces FDA Approval of Cequa (cyclosporine) Ophthalmic Solution to Treat Dry Eye Disease
August 19, 2018 - Researchers examining Parkinson’s resilience
August 19, 2018 - HPI, INTEGRIS and USPI enter into agreement to offer patients more choice, flexibility of care
August 19, 2018 - Researchers find mechanism that prepares brain to replicate repeated actions
August 19, 2018 - Those who are emotionally stable when young may remain the most stable as they age
August 19, 2018 - URI professor develops simpler and quicker method for detecting impurity in heparin
August 19, 2018 - Mayo Medical Laboratories and NDSC collaborate to develop new patient blood-management solution
August 19, 2018 - Insight into endocrine cancers and treatment options
August 19, 2018 - HPV Legislation Doesn’t Impact Teen Sexual Behaviors
August 19, 2018 - Exenatide treatment alleviated symptoms of depression in patients
August 19, 2018 - Tufts researchers win grant to study integration of genomic sequencing into neonatal care
August 19, 2018 - Novel finger-prick test can help prevent toxoplasmosis
August 19, 2018 - Cosmetic Procedures Boost Well-Being, Poll Shows
August 19, 2018 - Responsive parenting intervention results in lower BMIs through age three
August 19, 2018 - Anticancer drugs can help plants to battle infection
August 19, 2018 - Sunscreen from bathers releases significant quantities of polluting titanium dioxide into the sea
August 19, 2018 - Case Western Reserve gets three-year grant to enhance food systems in Cleveland neighborhoods
August 19, 2018 - Teenagers can thank their parents’ positive attitude for avoiding obesity
August 19, 2018 - Body mass index positively linked with blood pressure
August 19, 2018 - New tool fills gap in Small Molecules market
August 19, 2018 - Study compares survival outcomes in rural and urban cancer patients enrolled in clinical trials
August 19, 2018 - Researchers develop molecular matrix that delivers healing stem cells to injured elderly muscles
August 19, 2018 - Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
August 19, 2018 - New study pinpoints ways to improve quality of food and nutrition research
August 19, 2018 - Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody
August 19, 2018 - New CRISPR technology may help eliminate mutated gene sequence
August 19, 2018 - “Zombie gene” protects elephants from cancer finds study
August 19, 2018 - Study explores how many American cities protect the rights of employed breastfeeding mothers
August 19, 2018 - FDA Approves Lenvima (lenvatinib) for First-line Treatment of Unresectable Hepatocellular Carcinoma (HCC)
August 19, 2018 - Pain: Considering Complementary Approaches (eBook)
August 19, 2018 - Autoimmune response drives vision loss in glaucoma
August 19, 2018 - Tandem Diabetes Care introduces t:slim X2 Insulin Pump with Basal-IQ Technology in the US
August 19, 2018 - Innovative platform developed to destroy cancer cells
August 19, 2018 - Lowering pH inside tumor cells can slow down spread of cancer
August 19, 2018 - Biomarker predicts kidney cancer risk years before diagnosis
Panel Mulls Medicaid Exclusion of Some Residential Tx Facilities

Panel Mulls Medicaid Exclusion of Some Residential Tx Facilities

image_pdfDownload PDFimage_print

WASHINGTON — The Trump administration may want to re-think existing rules that exclude certain mental health and substance use residential treatment facilities from Medicaid reimbursement, members of the Medicaid and CHIP Payment and Access Commission (MACPAC) said Thursday.

When MACPAC gives Congress its annual report in June, “we have to be open with people who read our stuff to say [opioid addiction] is a crisis, we need to do something; that seems to be a good hypothesis and way to start,” said Christopher “Kit” Gorton, MD, former president for public plans at Tufts Health Plan, in Medford, Mass. However, he added, although current demonstration projects seem to indicate that including these facilities will likely lead to good outcomes, “I just think there should be a note of caution in what we write; we should be careful to say the jury’s still out.”

Gorton was referring to Medicaid’s “Institutions for Mental Diseases” (IMD) exclusion, which bars federal Medicaid dollars from being used to reimburse mental health or substance abuse treatment facilities with more than 16 beds.

Commission member Alan Weil, JD, editor-in-chief of Health Affairs, reminded his fellow MACPAC commissioners of how the exclusion came about. “The origin of the IMD exclusions was when they were large [state] facilities mostly, and the federal government didn’t want to pay for a state facility.” Today, many such treatment facilities are privately owned.

Erin McMullen, a principal analyst at MACPAC, pointed out in her introduction to the topic that there are two ways that states can work around the exclusion: they can apply for an 1115 waiver to do so, or they can adhere to the so-called “in lieu of” regulation, which allows manged care organizations that contract with Medicaid to use the facilities as long as they can be seen as medically necessary.

So far, eight states have used the 1115 waiver, and “and many others have applications pending,” McMullen said. In addition, “many states have expressed their intent to utilize the ‘in lieu of’ provision.” However, she added, “there is little information on whether substance use disorder patients experience treatment gains in residential settings, or whether [they would reap similar gains] from outpatient treatment.”

Residential treatment facilities need to be considered an important part of the continuum of care for patients with substance use disorders, along with acute care hospitals and outpatient treatment, said Yngvild Olsen, MD, MPH, medical director of REACH Health Services, a substance use recovery program in Baltimore, in her testimony to the commission.

Olsen said examples of typical patients who might benefit from residential care include:

  • An adult with polysubstance use disorders, including alcohol and/or benzodiazepines
  • A patient with no acute medical issues needing acute hospital care
  • Someone who is not actively suicidal or homicidal but who may have had passive thoughts of suicide in the past
  • Someone who is motivated at the moment for treatment
  • A patient with unstable housing and high relapse potential

In addition to the types of patients above, adolescents and pregnant women have a lower threshold for receiving residential care because of their special needs, she added.

Virginia was one of the states that used an 1115 waiver to avoid the IMD exclusion, explained Matthew Keats, MD, behavioral health medical director at the Virginia Department of Medical Assistance Services, in Richmond. Virginia’s waiver allows for federal matching funds to go toward treatment in an IMD, as along as the state and its Medicaid health plans use criteria developed by the American Society for Addiction Medicine to determine who gets which substance use disorder treatments.

The waiver was part of a new Medicaid substance use benefit program — known as Addiction Recovery and Treatment Services (ARTS) that the state started last July, Keats said. “Up to this point, we had very inadequate substance abuse coverage for members — no inpatient detox [services], a residential treatment program that was limited to pregnant women, and rates that were utterly inadequate — they didn’t even cover the cost of intensive outpatient treatment or residential treatment, so this was really a sea change,” he said. The state also raised its payment rates for substance use disorder treatment providers, “in some cases higher than commercial rates.”

Virginia saw a huge increase in the number of residential treatment providers as a result of the new program — it went from zero to 78, Keats said, adding that the use of substance use disorder services rose by 40%. In addition, opioid use disorder-related visits to emergency departments dropped 39% in the program’s first 5 months, he said.

The issue of changing the IMD rules raises other questions, said MACPAC chair Penny Thompson, MPA, a healthcare consultant in Ellicott City, Md. “If someone goes into residential treatment without a plan for maintaining treatment when they come out, or there is a question about what kind of treatment is actually being delivered in that residential setting … there is a need for additional guidelines” to be developed to address these issues, she said. “In the meantime, we have [an opioid addiction] crisis.”

Commissioner Martha Carter, CEO of FamilyCare Health Centers, a community health center in Scott Depot, W.Va., noted that health centers are also a major part of the continuum of care in many communities for these patients; federal funding for the health centers ran out in September and has not been renewed. “I have to assume they are going to get funded, but it makes business and hiring decisions very difficult,” she said.

Although residential treatment can be helpful, a note of caution would be good, said commissioner Charles Milligan, JD, MPH, CEO of UnitedHealthcare Community Plan of New Mexico, a Medicaid managed care plan. “There is sometimes a tendency to overbuild brick and mortar, and I think going to the highest level of care [should be done] most prudently and cautiously” so it doesn’t displace community health centers.

2018-01-25T17:45:00-0500

Tagged with:

About author

Related Articles